D. Gravenor

发表

A retrospective study to evaluate the work-up and follow-up of patients with monoclonal gammopathy of undetermined significance.

Siu-Fun Wong, J. Berenson, D. Colbourn, 2011, Clinical lymphoma, myeloma & leukemia.

A088 Overall Survival Among Patients with Multiple Myeloma (MM) Treated with Zoledronic Acid (ZOL)

I. Flinn, J. Crowley, J. Berenson, 2009 .

Phase I/II trial assessing bendamustine plus bortezomib combination therapy for the treatment of patients with relapsed or refractory multiple myeloma

E. Gorak, J. Berenson, S. Noga, 2013, British journal of haematology.

TITAN: phase III study of doxorubicin/cyclophosphamide followed by ixabepilone or paclitaxel in early-stage triple-negative breast cancer

J. Hainsworth, L. Bosserman, H. Burris, 2017, Breast Cancer Research and Treatment.

Replacement of bortezomib with carfilzomib for multiple myeloma patients progressing from bortezomib combination therapy

J. Berenson, A. Bessudo, R. Boccia, 2014, Leukemia.

Avelumab in patients with previously treated metastatic melanoma: phase 1b results from the JAVELIN Solid Tumor trial

J. Nemunaitis, L. Wyrwicz, Keun-Wook Lee, 2018, Journal of Immunotherapy for Cancer.

5α-Androstane-3α, 17β-Diol: Inhibitor of Sexual Maturation in the Female Rat

K. B. Ruf, D. Gravenor, S. J. Naish, 1981 .

Randomized phase II trial of a toll-like receptor 9 agonist oligodeoxynucleotide, PF-3512676, in combination with first-line taxane plus platinum chemotherapy for advanced-stage non-small-cell lung cancer.

C. Leichman, A. Krieg, V. Hirsh, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Avelumab in patients with previously treated metastatic melanoma: Phase 1b results from the JAVELIN Solid Tumor trial.

J. Nemunaitis, L. Wyrwicz, Keun-Wook Lee, 2018 .

Prognostic factors and jaw and renal complications among multiple myeloma patients treated with zoledronic acid

I. Flinn, V. Bolejack, J. Crowley, 2011, American journal of hematology.

Results of a phase I/II study (NCT01365559) of carfilzomib (CFZ) replacing bortezomib (BTZ) in BTZ-containing regimens for BTZ-treated patients (pts) with relapsed and refractory multiple myeloma (MM).

J. Berenson, A. Bessudo, R. Boccia, 2013 .

Tricyclic Antidepressant Agranulocytosis

J. Leclerc, D. Gravenor, G. Blake, 1986, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

Abstract P1-14-14: Neoadjuvant Sunitinib (S) Administered with Weekly Paclitaxel (P)/Carboplatin(C) in Patients (Pts) with Locally Advanced Triple-Negative Breast Cancer (TNBC): Preliminary Results from a Phase I/II Trial of the Sarah Cannon Research Institute.

H. Burris, C. Hendricks, D. Yardley, 2012 .

Clinical and Radiologic Resolution of IgG 4 Normal, Nonoperatively Diagnosed Lymphoplasmacytic Sclerosing Pancreatitis (LPSP) after Initiation of Steroid Therapy

S. Behrman, D. Gravenor, S. Moinuddin, 2007, Journal of Gastrointestinal Surgery.

CPG 7909, a TLR9 agonist, added to first line taxane/platinum for advanced non-small cell lung cancer, a randomized, controlled phase II study

J. Mezger, C. Manegold, D. Woytowitz, 2005 .